| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human Tissue factor pathway inhibitor |
|---|
| Description | 29-280aa; Partial. MW: 56.3kD. Purity >90% as determined by SDS-PAGE. Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex. It possesses an antithrombotic action and also the ability to associate with lipoproteins in plasma. |
|---|
| Size | 0.01 mg, 0.05 mg, 0.1 mg, 0.2 mg, 0.5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [Extrinsic pathway inhibitor; EPI; Lipoprotein-associated coagulation inhibitor; LACI] |
|---|
| Gene, Accession, CAS # | TFPI, Gene ID: 7035, Accession: NP_001027452.1 |
|---|
| Catalog # | MBS952804 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human Tissue factor pathway inhibitor from MYBIOSOURCE INC. |
|---|
| Product Specific References | Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.Wun T.-C., Kretzmer K.K., Girard T.J., Miletich J.P., Broze G.J. Jr.J. Biol. Chem. 263:6001-6004(1988) Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein.Girard T.J., Warren L.A., Novotny W.F., Bejcek B.E., Miletich J.P., Broze G.J. Jr.Thromb |
|---|
| 产品资料 |
|
|